Literature DB >> 10908683

Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story.

J S Smolen, W B Graninger, P Emery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10908683     DOI： 10.1093/rheumatology/39.7.689

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  Leflunomide in combination therapy for rheumatoid arthritis.

Authors:  Ruth L Savage
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

Review 2.  Leflunomide: friend or foe for systemic lupus erythematosus?

Authors:  Guo-Cui Wu; Xiao-Di Xu; Qiong Huang; Hua Wu
Journal:  Rheumatol Int       Date:  2012-09-08       Impact factor: 2.631

3.  Short-term efficacy and safety of leflunomide in the treatment of active rheumatoid arthritis in everyday clinical use : open-label, prospective study.

Authors:  Minh Nguyen; Marmar Kabir; Philippe Ravaud
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 4.  Conventional disease-modifying agents in rheumatoid arthritis - a review of their current use and role in treatment algorithms.

Authors:  Ivan Padjen; Mirna Reihl Crnogaj; Branimir Anić
Journal:  Reumatologia       Date:  2020-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.